Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy

Tuberculosis (TB) is top infectious disease killer caused by a single organism responsible for 1.5 million deaths in 2018. Both COVID-19 and the pandemic response are risking to affect control measures for TB and continuity of essential services for people affected by this infection in western count...

Full description

Saved in:

Bibliographic Details
Published in:	Infection Vol. 49; no. 5; pp. 1061 - 1064
Main Authors:	Musso, Maria, Di Gennaro, Francesco, Gualano, Gina, Mosti, Silvia, Cerva, Carlotta, Fard, Saeid Najafi, Libertone, Raffaella, Di Bari, Virginia, Cristofaro, Massimo, Tonnarini, Roberto, Castilletti, Concetta, Goletti, Delia, Palmieri, Fabrizio
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2021 Springer Nature B.V
Subjects:	Anergy Bacterial diseases Case Report Coronaviruses COVID-19 Developing countries Differential diagnosis Family Medicine General Practice Immune system Immunology Infectious Diseases Internal Medicine LDCs Medicine Medicine & Public Health Pandemics Patients Pneumonia Respiratory failure SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Tuberculosis Viral diseases COVID-19 SARS-CoV-2 Tuberculosis IGRA test
ISSN:	0300-8126, 1439-0973, 1439-0973
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!